Quantitative analysis for argenx SE (ARGX) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (62.0) (grade B). 39 signals analyzed (33 differentiated alt-data).
ARGX stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $776.49 | $754.85 | $776.02 |
| 2026-05-11 | $827.81 | $795.99 | $813.28 |
| 2026-05-21 | $827.66 | $797.83 | $816.22 |
| 2026-06-03 | $814.81 | $793.21 | $813.14 |
| 2026-06-15 | $892.89 | $876.65 | $884.20 |
| 2026-06-26 | $907.36 | $880.73 | $887.18 |
| 2026-07-09 | $925.31 | $905.45 | $909.49 |
| 2026-07-21 | $877.58 | $859.42 | $874.74 |
| 2026-07-31 | $873.08 | $846.16 | $853.82 |
| 2026-08-12 | $881.44 | $857.52 | $876.00 |
| 2026-08-24 | $1031.18 | $1001.51 | $1011.11 |
| 2026-09-03 | $1070.81 | $1052.78 | $1053.46 |
How argenx SE stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| TAK | Takeda Pharmaceutical Company Limited | $52.7B | — |
| HLN | Haleon plc | $41.2B | — |
| TEVA | Teva Pharmaceutical Industries Limited | $40.0B | — |
| ONC | BeOne Medicines Ltd. | $33.0B | — |
View all Health Care stocks by valuation and signals →
argenx SE (ARGX) scores Buy (62.0), with no measured dimension below 46. Its highest are technicals at 97, ML forecast at 77, across 4 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| technicals | 97 |
| ML forecast | 77 |
| analyst consensus | 55 |
| valuation | 46 |
StoQuant analyzes 39 signals (33 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on argenx SE (ARGX): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/ARGX"><img src="https://stoquant.com/badge/ARGX.svg" alt="argenx SE (ARGX) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.